tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 1 are a BUY (50%), 1 are a HOLD (50%).
Analyst Catherine Novack, currently employed at JONESTRADING,
Catherine Novack’s has documented 3 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KZR, Kezar Life Sciences at 05-Oct-2023.
Analyst best performing recommendations are on KZR (KEZAR LIFE SCIENCES).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$8.57 (249.85%)
$12
16 days ago
(15-Nov-2024)
1/4 (25%)
$8.79 (273.83%)
535
Hold
$4
3 months 17 days ago
(14-Aug-2024)
1/1 (100%)
$-15.44 (-79.42%)
660
Buy
$3
$-0.58 (-16.20%)
6 months 16 days ago
(15-May-2024)
1/2 (50%)
$-1.32 (-30.56%)
51
Buy
$2
$-1.43 (-41.69%)
1 years 3 months 1 days ago
(30-Aug-2023)
0/1 (0%)
$-6.52 (-76.53%)
Buy
$108
2 years 8 months ago
(01-Apr-2022)
0/1 (0%)
$85.32 (376.19%)
What Year was the first public recommendation made by Catherine Novack?
